Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Jiangsu Hengrui Pharma
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
7
14
21
28
35
42
49
56
63
70
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
retlirafusp alfa
(SHR-1701) / Jiangsu Hengrui Pharma
trastuzumab rezetecan
(SHR-A1811) / Jiangsu Hengrui Pharma
ivarmacitinib
(SHR0302) / Jiangsu Hengrui Pharma, Arcutis
ruzinurad
(SHR 4640) / Jiangsu Hengrui Pharma
SHR-2554
/ Treeline Biosci
SHR-A1921
/ Jiangsu Hengrui Pharma
plinabulin
(BPI 2358) / BeyondSpring
vunakizumab
(SHR-1314) / Jiangsu Hengrui Pharma
HRS9531 injection
/ Jiangsu Hengrui Pharma
otesaconazole
(VT-1161) / Mycovia Pharma
SHR0410
/ Jiangsu Hengrui Pharma
recaticimab
(SHR-1209) / Jiangsu Hengrui Pharma
SHR7280
/ Jiangsu Hengrui Pharma
long acting basal insulin
(INS068) / Jiangsu Hengrui Pharma
SHR-8068
/ Jiangsu Hengrui Pharma
ropivacaine liposomal sustained release
(HR18034) / Jiangsu Hengrui Pharma
SHR-1703
/ Jiangsu Hengrui Pharma
SHR-1819
/ Jiangsu Hengrui Pharma
SHR8554
/ Jiangsu Hengrui Pharma
irinotecan hydrochloride liposome injection
(HR070803) / Jiangsu Hengrui Pharma
HR091506
/ Jiangsu Hengrui Pharma
dexmedetomidine nasal spray
/ Jiangsu Hengrui Pharma
HR20013
/ Jiangsu Hengrui Pharma
pregabalin sustained-release
/ Jiangsu Hengrui Pharma
